EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chitosan/Hesperidin Nanoparticles for Sufficient, Compatible, Antioxidant, and Antitumor Drug Delivery Systems

May Almukainzi iD, Thanaa A El-Masry, Enas I El Zahaby iD, Maysa M F El-Nagar iD

Pharmaceuticals · 29.07.2024 · 17 (8) · 999

DOI: 10.3390/ph17080999 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 29.07.2024. Verfasst von May Almukainzi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One flavonoid glycoside with demonstrated therapeutic potential for several illnesses, including cancer, is hesperidin. However, because of its limited bioavailability and solubility, it is only marginally absorbed, necessitating a delivery mechanism to reach the intended therapeutic target. Additionally, the cytoskeleton of crustaceans yields chitosan, a naturally occurring biopolymer with mucoadhesive properties that has been used to improve the absorption of advantageous chemical substances like flavonoids. Chitosan/hesperidin nanoparticles (Hes-Nanoparticles) were made using the ion gelation technique. The synthesis of Hes-Nanoparticles was confirmed by several characterization methods, including the swelling test, zeta potential, particle size, FTIR, XRD, TEM, and SEM. DPPH and ABTS were used to demonstrate radical scavenging activity in antioxidant assays of chitosan, hesperidin, and the synthesized Hes-Nanoparticles. In addition, by a viability assay against MDA-MB-231, the anticancer efficacies of chitosan, hesperidin, and the synthesized Hes-Nanoparticles were assessed. Furthermore, annexin-V/PI double staining and the cycle of cell analysis were determined by flow cytometry. The results displayed that Hes-Nanoparticles have higher antioxidant activity than chitosan and hesperidin alone. Also, it has been demonstrated that Hes-Nanoparticles are more effective in early cell cycle arrest, suppressing the viability of cancer cells, and increasing cell apoptosis than chitosan and hesperidin alone. In conclusion, Hes-Nanoparticles demonstrated more antioxidant and antitumor activities than chitosan and hesperidin alone. Moreover, it has been established that Hes-Nanoparticles, in a highly soluble form, increase activity in contrast to the poorly soluble form of hesperidin alone.

Schlagwörter

Stichwörter der Autor:innen

antioxidantantitumorchitosanchitosan/hesperidin nanoformulationhesperidin

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
  • Department of Pharmaceutics, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 35712, Egypt.

ORCID-Profile: May Almukainzi, Enas I El Zahaby, Maysa M F El-Nagar

Förderung

  • Princess Nourah bint Abdulrahman University

Zitieren

APA

Almukainzi, M., El-Masry, T. A., El Zahaby, E. I., & El-Nagar, M. M. F. (2024). Chitosan/Hesperidin Nanoparticles for Sufficient, Compatible, Antioxidant, and Antitumor Drug Delivery Systems. Pharmaceuticals, 17(8), 999. https://doi.org/10.3390/ph17080999

Vancouver

Almukainzi M, El-Masry TA, El Zahaby EI, El-Nagar MMF. Chitosan/Hesperidin Nanoparticles for Sufficient, Compatible, Antioxidant, and Antitumor Drug Delivery Systems. Pharmaceuticals. 2024;17(8):999. doi:10.3390/ph17080999

BibTeX
@article{Almukainzi2024,
  author = {Almukainzi, May and El-Masry, Thanaa A and El Zahaby, Enas I and El-Nagar, Maysa M F},
  title = {Chitosan/Hesperidin Nanoparticles for Sufficient, Compatible, Antioxidant, and Antitumor Drug Delivery Systems},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {8},
  pages = {999},
  doi = {10.3390/ph17080999}
}
Kostenlos starten →